CStone Pharmaceuticals (STU:PH4) Interest Expense : €-1.51 Mil (TTM As of Jun. 2023)

View and export this data going back to 2019. Start your Free Trial

What is CStone Pharmaceuticals Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. CStone Pharmaceuticals's interest expense for the six months ended in Jun. 2023 was € -0.76 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2023 was €-1.51 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. CStone Pharmaceuticals's Operating Income for the six months ended in Jun. 2023 was € -31.39 Mil. CStone Pharmaceuticals's Interest Expense for the six months ended in Jun. 2023 was € -0.76 Mil. CStone Pharmaceuticals did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

CStone Pharmaceuticals Interest Expense Historical Data

The historical data trend for CStone Pharmaceuticals's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CStone Pharmaceuticals Interest Expense Chart

CStone Pharmaceuticals Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-0.04

-0.17

-0.31

-1.15

-1.52

CStone Pharmaceuticals Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Interest Expense	Get a 7-Day Free Trial									-0.01	-0.42	-0.75	-0.76	-

CStone Pharmaceuticals Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-1.51 Mil.

CStone Pharmaceuticals (STU:PH4) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

CStone Pharmaceuticals's Interest Expense for the six months ended in Jun. 2023 was €-0.76 Mil. Its Operating Income for the six months ended in Jun. 2023 was €-31.39 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Jun. 2023 was €0.00 Mil.

CStone Pharmaceuticals's Interest Coverage for the quarter that ended in Jun. 2023 is calculated as

CStone Pharmaceuticals did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

CStone Pharmaceuticals (STU:PH4) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CStone Pharmaceuticals (STU:PH4) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

CSPHF:USA 02616:Hong Kong

Address

218 Xinghu Street, C1 Building, North Block, Suzhou Industrial Park, Shanghai, CHN, 215123

Website

https://www.cstonepharma.com

CStone Pharmaceuticals is engaged in the development and commercialization of innovative tumor immunotherapy and molecular-targeted drugs. It has been operating in one reportable segment, the research and development of complex biopharmaceutical products.

CStone Pharmaceuticals (STU:PH4) Headlines

No Headlines